Companies / Akebia Therapeutics, Inc. / Activity
Activity — Akebia Therapeutics, Inc.
35 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Butler John P. CEO | Grant | Common Stock | $247.1K | +175K +5.47% | 3,381,483 1.22% of shares | low |
| Feb 2, 2026 | Butler John P. CEO | Sell | Common Stock | $159.7K | -115K -3.46% | 3,206,233 1.16% of shares | medium |
| Feb 2, 2026 | Butler John P. CEO | Sell | Common Stock | $133.5K | -96K -2.81% | 3,321,124 1.20% of shares | medium |
| Feb 2, 2026 | Butler John P. CEO | Sell | Common Stock | $116.3K | -84K -2.47% | 3,297,794 1.19% of shares | medium |
| Mar 4, 2026 | Butler John P. CEO | Buy | Common Stock | $86.6K | +69K +2.10% | 3,367,064 1.22% of shares | medium |
| Feb 2, 2026 | Grund Nicholas Executive | Sell | Common Stock | $74.5K | -54K -8.29% | 592,994 0.21% of shares | low |
| Feb 2, 2026 | Butler John P. CEO | Sell | Common Stock | $64.9K | -47K -1.35% | 3,417,189 1.23% of shares | low |
| Feb 2, 2026 | Malabre Richard C Executive | Sell | Common Stock | $50.2K | -36K -10.36% | 312,772 0.11% of shares | low |
| Feb 2, 2026 | Ostrowski Erik Executive | Sell | Common Stock | $48.6K | -35K -4.94% | 672,635 0.24% of shares | low |
| Feb 2, 2026 | Grund Nicholas Executive | Sell | Common Stock | $43.4K | -31K -5.27% | 561,750 0.20% of shares | low |
| Feb 2, 2026 | Rucci Carolyn M. Executive | Sell | Common Stock | $38.3K | -28K -4.47% | 588,378 0.21% of shares | low |
| Feb 2, 2026 | Rucci Carolyn M. Executive | Sell | Common Stock | $35.3K | -25K -3.96% | 615,922 0.22% of shares | low |
| Feb 2, 2026 | Burke Steven Keith Executive | Sell | Common Stock | $35.3K | -25K -2.55% | 969,133 0.35% of shares | low |
| Feb 2, 2026 | Burke Steven Keith Executive | Sell | Common Stock | $30.0K | -22K -2.12% | 994,508 0.36% of shares | low |
| Feb 2, 2026 | Burke Steven Keith Executive | Sell | Common Stock | $28.8K | -21K -2.14% | 948,432 0.34% of shares | low |
| Feb 2, 2026 | Rucci Carolyn M. Executive | Sell | Common Stock | $23.4K | -17K -2.56% | 641,304 0.23% of shares | low |
| Feb 2, 2026 | Malabre Richard C Executive | Sell | Common Stock | $18.6K | -13K -4.28% | 299,390 0.11% of shares | low |
| Jun 17, 2026 | Adams Adrian Director | Grant | Common Stock | $0 | +36K +17.81% | 236,200 0.09% of shares | low |
| Jun 17, 2026 | Rogers Michael W Director | Grant | Common Stock | $0 | +36K +22.07% | 197,429 0.07% of shares | low |
| Jun 17, 2026 | Zumwalt Leanne M Director | Grant | Common Stock | $0 | +36K +32.63% | 145,100 0.05% of shares | low |
| Jan 30, 2026 | Ostrowski Erik Executive | Grant | Common Stock | $0 | +204K +40.51% | 707,586 0.26% of shares | low |
| Jan 30, 2026 | Grund Nicholas Executive | Grant | Common Stock | $0 | +204K +46.09% | 646,579 0.23% of shares | low |
| Jan 30, 2026 | Burke Steven Keith Executive | Grant | Common Stock | $0 | +204K +25.12% | 1,016,090 0.37% of shares | low |
| Jan 30, 2026 | Butler John P. CEO | Grant | Common Stock | $0 | +743K +27.31% | 3,463,849 1.25% of shares | low |
| Jan 30, 2026 | Rucci Carolyn M. Executive | Grant | Common Stock | $0 | +190K +40.59% | 658,150 0.24% of shares | low |
| Jan 30, 2026 | Malabre Richard C Executive | Grant | Common Stock | $0 | +79K +29.27% | 348,914 0.13% of shares | low |
| Jun 17, 2026 | Adams Adrian Director | Grant | Stock Option (Right to buy) | — | +54K | 53,600 0.02% of shares | low |
| Jun 17, 2026 | Rogers Michael W Director | Grant | Stock Option (Right to buy) | — | +54K | 53,600 0.02% of shares | low |
| Jun 17, 2026 | Zumwalt Leanne M Director | Grant | Stock Option (Right to buy) | — | +54K | 53,600 0.02% of shares | low |
| Jan 30, 2026 | Ostrowski Erik Executive | Grant | Stock Option (Right to buy) | — | +320K | 320,000 0.12% of shares | low |
| Jan 30, 2026 | Grund Nicholas Executive | Grant | Stock Option (Right to buy) | — | +320K | 320,000 0.12% of shares | low |
| Jan 30, 2026 | Burke Steven Keith Executive | Grant | Stock Option (Right to buy) | — | +320K | 320,000 0.12% of shares | low |
| Jan 30, 2026 | Butler John P. CEO | Grant | Stock Option (Right to buy) | — | +1.1M | 1,115,000 0.40% of shares | low |
| Jan 30, 2026 | Rucci Carolyn M. Executive | Grant | Stock Option (Right to buy) | — | +270K | 270,000 0.10% of shares | low |
| Jan 30, 2026 | Malabre Richard C Executive | Grant | Stock Option (Right to buy) | — | +119K | 119,000 0.04% of shares | low |